Area of research
Infectious Diseases · Virology
Research interest
Research interests include Virology, Medicine, Antibody, Immune system, Immunogenicity, and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Hyper-reactivity of CD8+ T cells and high expression of IL-3 correlates with occurrence and severity of Long-COVID
SARS-CoV-2 spike epitopes as a novel clinically-relevant biomarker for post-COVID syndrome 3558
Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits
Longitudinal effects of SARS-CoV-2 breakthrough infection on imprinting of neutralizing antibody responses
Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cells
Prolonged delivery of HIV-1 vaccine nanoparticles from hydrogels
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
DNA origami traps for large viruses
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
Liposome-based high-throughput and point-of-care assays toward the quick, simple, and sensitive detection of neutralizing antibodies against SARS-CoV-2 in patient sera
DNA Extraction from Clotted Blood in Genotyping Quality
Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice
Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from people with cystic fibrosis
Potency and durability of T and B cell immune responses after homologous and heterologous vector delivery of a trimer-stabilized, membrane-displayed HIV-1 clade ConC Env protein
Assessing immunogenicity barriers of the HIV-1 envelope trimer
IgG4 serum levels are not elevated in cases of Post-COVID syndrome
Scorpionfish BPI is highly active against multiple drug-resistant <i>Pseudomonas aeruginosa</i> isolates from cystic fibrosis patients
Author response: Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from people with cystic fibrosis
Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals
Targeted escape of SARS-CoV-2 in vitro from monoclonal antibody S309, the precursor of sotrovimab
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants
Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County—Results from a Population-Based Longitudinal Study in Germany
Multivalent display of engineered HIV-1 envelope trimers on silica nanoparticles for targeting and in vitro activation of germline VRC01 B cells
Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination
Association between Adverse Reactions and Humoral Immune Response No Longer Detectable after BNT162b2 Booster Vaccination
Higher Infection Risk among Health Care Workers and Lower Risk among Smokers Persistent across SARS-CoV-2 Waves—Longitudinal Results from the Population-Based TiKoCo Seroprevalence Study
Niedrige Inzidenz von SARS-CoV‑2-Infektionen bei Krankenhausmitarbeitern eines Maximalversorgers
Gene delivery of a single,structurally engineered Coronavirus vaccine antigen elicits SARS-CoV-2 Omicron and pan-Sarbecovirus neutralisation